Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial RespirationIga Walczak, Barbara Kutryb-Zając, Alicja Braczko et al.|Cellular Physiology and Biochemistry|2025Cited by 6
Special focus on the mitochondria in endothelial cells: A novel therapeutic target for gliflozins?Maria Tarnawska, Barbara Kutryb-Zając, Aleksandra Paterek et al.|Biomedicine & Pharmacotherapy|2025Cited by 3